Summary:
A randomized, double blind, parallel group to assess the efficacy and safety of PT009 compared to PT005 on COPD exacerbations over a 52-week period with patients having moderate to very severe COPD.
Qualified Participants Must:
• Be between 40 and 80 years of age
•
Have been diagnosed with moderate to very severe COPD for at least 1 year
•
Must have been hospitalized at least 1 time for their COPD in the last year or have seen a doctor at least twice for worsening symptoms of their COPD
•
Have no current diagnosis of Asthma.
Must smoke or have smoked in the past.
Qualified Participants May Receive:
Study COPD medication, study exams and labs, study breathing tests, X-rays and compensation at every visit.